NCT01341353

Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China

Atrial Fibrillation Therapy: A Multi-Center Clinical Study

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,800 (estimated)
• Sponsor: Wuhan University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The mainstay of treatment for atrial fibrillation remains pharmacological;however,catheter ablation has increasingly been used over the last decades. The relative merits of each strategy have not been extensively studied. Our study was designed to determine if catheter ablation is a feasible option as first-line therapy for treating patients with symptomatic AF.

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
PROCEDURE	catheter ablation	circumferential pulmonary vein isolation complex fractionated atrial electrograms ablation circumferential pulmonary vein isolation combined left atrial roof ablation circumferential pulmonary vein isolation combined left atrial isthmus ablation circumferential pulmonary vein isolation combined left atrial roof and isthmus ablation circumferential pulmonary vein isolation combined complex fractionated atrial electrograms ablation
DRUG	Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists

Timeline

• Start date: 2011-04-01
• Primary completion: 2014-12-01
• Completion: 2015-12-01
• First posted: 2011-04-25
• Last updated: 2011-04-25

Locations

1 site across 1 country: China